Abstract
A study of 180 healthy cats found that 15.6% were feline leukemia virus (FeLV) positive, 8.3% were feline immunodeficiency virus (FIV) positive, and 1.1% were FIV and FeLV positive, which corresponded to 30.4, 13.8, and 2.6, of 115 cats with FIV- and FeLV-related symptoms, respectively. Differences were seen in the sexes and ages of the populations studied. Anemia, leukopenia, and lymphopenia were the most frequent hematological abnormalities in infected cats.
Two of the three members of the family Retroviridae described in cats are pathogenic: feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Both retroviruses have a worldwide distribution. FeLV is transmitted primarily by saliva and respiratory secretions, but it is also secreted by urine, feces, tears, and milk (3, 8). Contagion occurs through the sharing of food and drink containers and by behavior such as grooming of one another. FIV is very similar to human immunodeficiency virus type 1 (HIV-1), to the extent that it has been proposed as the best animal model with which to study the pathogenesis of HIV-1 and therapy for humans infected with the virus (3). FIV is shed mainly in the saliva (8) and is transmitted mostly through bite wounds (4, 8, 19), but it is also transmitted in utero or through colostrum and milk (8). FIV induces a progressive immune dysfunction, which develops for months or even years.
The aim of the present work was to estimate the percentage of healthy and symptomatic cats in Madrid infected with the feline retroviruses (FeLV and FIV) as representative of the situation in urban areas in Spain. Some epidemiological parameters of the infected cats such as sex, age, and origin were also studied. Hematological values and renal function were compared between healthy and sick cats.
Cats from the Madrid metropolitan area were sampled between January and November 1999. Group H included 180 healthy animals brought to a veterinary practice for vaccination or a routine checkup. Group S included 115 animals that showed signs such as anorexia, depression, fever, lymphomegaly, stomatitis, rhinotracheitis, generalized skin infections, or tumors which could be related to infection with feline retroviruses. Data collected from the animals included age, sex, origin, lifestyle, and vaccination and clinical histories. Blood was collected from the animals to determine whether they were infected with FIV and/or FeLV by using a commercial kit (Snap Combo Plus R; Idexx, Inc., Westbrook, Maine). According to the literature, the sensitivity and specificity of this type of enzyme-linked immunosorbent assay range between 93 and 100% (2, 5, 9, 13, 17).
Among the 180 cats in group H, 15.6% were found to be FeLV positive, 8.3% were FIV positive, and 1.1% were positive for both viruses. With respect to the 115 animals in group S, 30.4% were FeLV positive, 13.9% were FIV positive, and 2.6% were positive for both viruses. Among the cats in group H, the prevalence of FeLV agrees with data from other studies: 18% in Italy (1) and 13.4% in Germany (6). In the case of the percentage of cats infected with FIV, results were also similar to those of previous studies in Western Europe: 11% in France (4) and 6% in the United Kingdom (11). Other studies obtained different prevalences of infected cats: 2% FeLV-positive cats in Sydney, Australia (15), 1.2% FeLV-positive cats in Norway (18), 0.7% FIV-positive cats in Switzerland (14), and 44% FIV-positive cats in Japan (12). These differences are probably related to sociocultural circumstances, which determine the lifestyles and origins of the domestic cats and possibilities for interactions between infected and noninfected cats. As might be expected, the percentage of cats infected with FeLV, FIV, and both viruses was almost double in cats in group S compared with that in cats in group H. It is worth mentioning that the clinical signs are very nonspecific, and a high percentage of animals with clinical signs suggestive of infection with FIV or by FeLV were negative for both retroviruses.
To study the influence of age, cats were classified in three categories: young (<3 years old), mature (3 to 8 years old), and senior (>8 years old). Among the cats in group H, 70% of the FeLV-positive animals were young, 20% were mature, and 10% were senior. Among the FIV-positive cats in group H, the proportions were 20, 60, and 20%, respectively. Among the FeLV-positive cats in group S, 50.1% were young, 42.8% were mature, and 7.1% were senior cats. Among the FIV-positive cats in group S, the age distributions were 33.4, 55.5, and 11.1%, respectively. The average older age of FIV-positive cats in group H probably reflects the fact that FIV is more easily transmissible by bites. Besides transmission from queens, the fact that FeLV-positive animals were younger than FIV-positive animals may also indicate that animals infected with FeLV die at a younger age and fewer infected animals reach an older age.
When classified by sex, the percentages of FeLV-positive or FIV-positive males in group H (63.2 and 83.3%, of the 103 animals whose sexes were known, respectively) were significantly higher than those for females (P < 0.05). On the other hand, the proportions of FeLV-positive and FIV-positive males among the 94 cats in group S were only 41.4 and 50%, respectively. These differences were significant (P < 0.05). These data seem to indicate that sex may somehow influence the development of signs related to FeLV or FIV infection. Other investigators (10) have also detected sex-related differences in the rate of FIV positivity among cats, especially in the sense that estradiol may protect peripheral lymphocytes from apoptosis after stimulation.
The number of red blood cells (RBCs), the number of leukocytes (WBCs), and the leukocyte formula were determined for 27 FeLV-positive, 9 FIV-positive and 43 FIV- and FeLV-negative cats, including cats in both groups H and S. The intervals considered normal were 5.5 million to 10 million RBCs/μl, 5,500 to 19,500 WBCs/μl, 35 to 75% neutrophils, and 20 to 55% lymphocytes. Fifty percent of the FeLV-positive cats, 44% of the FIV-positive cats, but only 14% of the FIV- and FeLV-negative cats had anemia. Thus, FeLV and FIV infections seem to be related to anemia, even though there was only a statistical association with FeLV infection (P < 0.05). Concerning the number of WBCs, 46.2% of the FeLV-positive cats had leukopenia, while 30.8% had leukocytosis. There was a statistical association between leukopenia and infection with FeLV (P < 0.05). This agrees with the fact that the most frequent clinical manifestation in cats infected with FeLV is the development of secondary infections due to severe immunodeficiency (7). In the case of cats infected with FIV, there was no predominant alteration, which may indicate that the animals studied were in different clinical stages of the disease, each one characterized by a specific alteration. The most frequent variations were neutropenia (33.3% of FeLV-positive cats) and lymphopenia (37.5% of FIV-positive cats).
Some investigators have suggested that infection with feline retroviruses may induce renal lesions due to the deposit of immune complexes in renal tissues (12, 16). Urea and creatinine levels were determined in 213 plasma samples of cats in groups H and S; 48 of them were FeLV positive and 25 were FIV positive. High urea levels (>20 to 50 mg of urea/dl) were seen in 45.8% of the FeLV-positive cats, 62.5% of the FIV-positive cats, and 51% of the FIV- and FeLV-negative cats. The proportions of animals in these three groups with high creatinine levels (>1 to 2 mg of creatinine/dl) were 9.1, 16.7, and 13.2%, respectively. Thus, in the present study, no significant difference was seen in the values of urea and creatinine (suggestive of renal failure) between noninfected and infected cats. However, the absence of renal lesions may be confirmed only by histological techniques.
From the results of this study, we may conclude that an important percentage of cats are infected with FIV and FeLV and have no clinical signs. Accordingly, the everyday veterinary practice should aim to detect these retroviruses in all cats that come to the practice for the first time in order to control the infection. In addition, FIV and FeLV detection is also necessary for sick cats, as the clinical signs are varied and nonspecific, so that appropriate measures can be taken, especially avoidance of free roaming.
Acknowledgments
We thank the veterinary practitioners who have participated in this study. In this sense, we are especially grateful to Gustavo Sanchez Visconti and the personnel of the Laboratorio de Analisis Veterinarios, as well as the staff of the Hospital Clinico Veterinario, for their kind collaboration. The assistance of Jose Antonio Ruiz-Santa-Quiteria in the epidemiological study and David Bruhn for his editorial work are gratefully acknowledged.
This work was supported by grants from the Spanish government (CAM-08.2/0011/98/98 and DGES-PM98-0077/98).
REFERENCES
- 1.Bandecchi P, Matteucci D, Baldinotti F, Guidi G, Abramo F, Tozzini F, Bendinelli M. Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy. Vet Immunol Immunopathol. 1992;31:337–345. doi: 10.1016/0165-2427(92)90020-q. [DOI] [PubMed] [Google Scholar]
- 2.Barr M C, Pough M B, Jacobson R H, Scott F W. Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection. J Am Vet Med Assoc. 1991;199:1377–1381. [PubMed] [Google Scholar]
- 3.Bendinelli M, Pistello M, Lombardi S, Poli A, Garzelli C, Matteucci D, Ceccherini-Nelli L, Malvaldi G, Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev. 1995;8:87–112. doi: 10.1128/cmr.8.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Courchamp F, Pointer D. Feline immunodeficiency virus: an epidemiological review. C R Acad Sci Ser III. 1994;317:1123–1134. [PubMed] [Google Scholar]
- 5.del Fierro G M, Bundesen P, Martin S, Jones S, Beetson S, Robinson W F. Evaluation of an autologous red cell agglutination test, VetRED FIV, for the presence of FIV antibody in cats. Vet Immunol Immunopathol. 1995;46:93–101. doi: 10.1016/0165-2427(94)07009-v. [DOI] [PubMed] [Google Scholar]
- 6.Fuchs A, Binzel L, Lonsdorfer M. Epidemiology of FeLV and FIV infection in the Federal Republic of Germany. Tierarztl Prax. 1994;22:273–277. [PubMed] [Google Scholar]
- 7.Hardy W D, Jr, Essex M. FeLV-induced feline acquired immune deficiency syndrome (FAIDS). A model for human AIDS. Prog Allergy. 1986;37:353–376. doi: 10.1159/000318453. [DOI] [PubMed] [Google Scholar]
- 8.Hartmann K. Feline immunodeficiency virus infection: an overview. Vet J. 1998;155:123–137. doi: 10.1016/S1090-0233(98)80008-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hawks D M, Legendre A M, Rohrbach B W. Comparison of four test kits for feline leukemia virus antigen. J Am Vet Med Assoc. 1991;199:1373–1376. [PubMed] [Google Scholar]
- 10.Hofmann-Lehmann R, Holznagel E, Lutz H. Female cats have lower rates of apoptosis in peripheral blood lymphocytes than male cats: correlation with estradiol-17beta, but not with progesterone blood levels. Vet Immunol Immunopathol. 1998;65:151–160. doi: 10.1016/s0165-2427(98)00150-0. [DOI] [PubMed] [Google Scholar]
- 11.Hosie M J, Robertson C, Jarrett O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec. 1989;125:293–297. doi: 10.1136/vr.125.11.293. [DOI] [PubMed] [Google Scholar]
- 12.Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, Pedersen N C. Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc. 1989;194:221–225. [PubMed] [Google Scholar]
- 13.Jacobson R H, Lopez N A. Comparative study of diagnostic testing for feline leukemia virus infection. J Am Vet Med Assoc. 1991;199:1389–1391. [PubMed] [Google Scholar]
- 14.Lutz H, Lehmann R, Winkler G, Kottwitz B, Dittmer A, Wolfensberger C, Arnold P. Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses. Schweiz Arch Tierheilkd. 1990;132:217–225. [PubMed] [Google Scholar]
- 15.Malik R, Kendall K, Cridland J, Coulston S, Stuart A J, Snow D, Love D N. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust Vet J. 1997;75:323–327. doi: 10.1111/j.1751-0813.1997.tb15701.x. [DOI] [PubMed] [Google Scholar]
- 16.Poli A, Abramo F, Matteucci D, Baldinotti F, Pistello M, Lombardi S, Barsotti P, Bendinelli M. Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis. Vet Immunol Immunopathol. 1995;6:13–20. doi: 10.1016/0165-2427(94)07002-o. [DOI] [PubMed] [Google Scholar]
- 17.Swango L J. Evaluation of feline leukemia virus diagnostic tests available for in-office use by veterinarians. J Am Vet Med Assoc. 1991;199:1386–1389. [PubMed] [Google Scholar]
- 18.Ueland K, Lutz H. Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway. Zentbl Vet Med B. 1992;39:53–58. doi: 10.1111/j.1439-0450.1992.tb01137.x. [DOI] [PubMed] [Google Scholar]
- 19.Yamamoto J K, Hansen H, Ho E W, Morishita T Y, Okuda T, Sawa T R, Nakamura R M, Pedersen N C. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc. 1989;194:213–220. [PubMed] [Google Scholar]